Janik Martin

Mr. Janik Martin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
ECElisa Corazza
Elisa Corazza
JMJanik Martin
Janik Martin
Barbara GiordaniBarbara Giordani
Barbara Giordani
Beatrice VitaliBeatrice Vitali
Beatrice Vitali
MRMartina Rossi
Martina Rossi
Katharina Schindowski ZimmermannKatharina Schindowski Zimmermann
Katharina Schindowski Zimmermann
Concerns about environmental health are driving pharmaceutical industries towards more eco-friendly and biocompatible products. Lactobacilli cell-free supernatants (CFS) are mixtures of soluble factors derived from the microbial growth of beneficial bacteria with the potential to serve as natural and sustainable excipients in emerging formulations. This work aims to verify the usefulness of the CFS obtained from human L. crispatus BC5, L. gasseri BC9 and BC12 as enhancers in the nose-to-brain absorption of small hydrophilic molecules. CFS influence on cell viability was investigated together with their ability to increase the diffusion of sodium fluorescein across in vitro models of the olfactory epithelium. The enhancing mechanism was studied through differential scanning calorimetry analysis and immunostaining assay of zonula occludens-1. The use of 25 % (v/v) of all lactobacilli CFS on porcine olfactory epithelial primary cells was not associated with any cytotoxic effect, but only the CFS obtained from BC5 was pointed out as a permeation enhancer across both the biomimetic membrane PermeaPad®, the porcine olfactory tissue, and the primary cell model. The enhancing mechanism seems to rely on the CFS perturbation effect on lipid membranes that, in the case of the cell-based model, probably also results in an alteration of tight junctions’ activity.

2 April 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JMJanik Martin
Janik Martin
VNVeronika Neubauer
Veronika Neubauer
RRRebecca Rittersberger
Rebecca Rittersberger
STSimon Treitler
Simon Treitler
PKPatrick Kopp
Patrick Kopp
Katharina Schindowski ZimmermannKatharina Schindowski Zimmermann
Katharina Schindowski Zimmermann
Background/Objectives: In vitro models play a crucial role in preclinical respiratory research, enabling the testing and screening of mucosal formulations, dosage forms, and inhaled drugs. Mucociliary clearance (MCC) is an essential defense mechanism in mucosal drug delivery but is often impaired in respiratory diseases. Despite its importance, standardized in vitro MCC assays are rarely reported. Furthermore, many published methods primarily measure cilia beat frequency (CBF), which requires high-speed cameras that are not accessible to all laboratories. Therefore, this study aimed to develop a physiologically relevant, differentiated in vitro model of the respiratory epithelium that incorporates both beating cilia and functional MCC. We chose porcine airway mucosa as an alternative to human tissue due to ethical considerations and limited availability. The established model is designed to provide a reproducible and accessible method for a broad range of research laboratories. Methods: The previously published tracheal mucosal primary cell (TMPC DS) model, derived from porcine tissue, lacked the presence of beating cilia, which are crucial for effective MCC analysis. For accurate MCC assessment, beating cilia are essential as they play a key role in mucus clearance. To address this limitation, the here-described ciliated tracheal mucosal primary cell (cTMPC) model was developed. cTMPCs were isolated from porcine tissue and cultured under air–liquid interface (ALI) conditions for 21 days to promote differentiation. This model was evaluated for cell morphology, tight junction formation, ciliated and mucus-producing cells, barrier function, gene expression, and tracer/IgG transport. MCC and the model’s suitability for standardized MCC assays were assessed using an inverted microscope. In contrast to the TMPC DS model, which lacked beating cilia and thus could not support MCC analysis, the cTMPC model allows for comprehensive MCC studies. Results: The developed differentiated in vitro model demonstrated key structural and functional features of the respiratory epithelium, including well-differentiated cell morphology, tight junction integrity, ciliated and mucus-producing cells, and effective barrier function. Functional MCC was observed, confirming the model’s potential for standardized clearance assays. Conclusions: This differentiated in vitro model closely replicates the structural and functional characteristics of in vivo airways. It provides a valuable platform for studying mucociliary clearance, toxicology, drug uptake, and evaluating mucosal formulations and dosage forms in respiratory research.